tirzepatide launch date Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide Market Forecast Tirzepatide drug

During the delivery of Pluvicto, imaging can identify PSMA-positive tumors through a PET scan

GGC has a credible biochemical basis and clinical evidence of cellular bioavailability

In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers

Beyond Cagrilintide and Survodutide, our extensive catalog includes a wide array of peptides for metabolic research, such as [Orforglipron Tablets]( and compounds within our [Fat Loss & Metabolic Health Bundle]( Were committed to being a comprehensive resource for your lab